Paper4041682
Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug.
Brittain RT and 3 others. Br J Pharmacol, 1985. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug. Papers, record 4041682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4041682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoid Tumor | Major topic |
| Receptors, Histamine | Major topic |
| Receptors, Histamine H2 | Major topic |
| Stomach Neoplasms | Major topic |
| Triazoles | Major topic |
| Animals | |
| Dose-Response Relationship, Drug | |
| Female | |
| Gastric Acid | |
| Histamine | |
| Ranitidine | |
| Rats |
Source PubMed
References2
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6112034 | Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/6112034 | PubMed |
| 3 | 13651579 | Some quantitative uses of drug antagonists. | Br J Pharmacol Chemother | 1959 | https://conductscience.org/library/papers/13651579 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42582236 | Perspectives on gastric cancer: the central role of gastrin in carcinogenesis by Helicobacter pylori, oxyntic atrophy and drug-induced acid suppression. | Front Oncol | 2026 | https://conductscience.org/library/papers/42582236 | PubMed |
| 10461361 | Clinical aspects of ECL-cell abnormalities. | Yale J Biol Med | 1998 | https://conductscience.org/library/papers/10461361 | PubMed |
| 9038657 | 1976 and all that!--20 years of antisecretory therapy. | Gut | 1996 | https://conductscience.org/library/papers/9038657 | PubMed |
| 8565741 | Observations on relationship between hypergastrinemia, multiple gastric carcinoids, and pancreatic mass. | Dig Dis Sci | 1996 | https://conductscience.org/library/papers/8565741 | PubMed |
| 8307483 | Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome. | Gut | 1994 | https://conductscience.org/library/papers/8307483 | PubMed |
| 8097370 | Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockade. | Am J Pathol | 1993 | https://conductscience.org/library/papers/8097370 | PubMed |
| 7828970 | Evaluation of the trophic effect of longterm treatment with the histamine H2 receptor antagonist loxtidine on rat oxyntic mucosa by differential counting of dispersed cells. | Gut | 1994 | https://conductscience.org/library/papers/7828970 | PubMed |
| 7648966 | Role of prostaglandins and histamine in hyperemic response to superficial and deep gastric mucosal injury and H+ back-diffusion in cats. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7648966 | PubMed |
| 3556339 | Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis? | Gut | 1987 | https://conductscience.org/library/papers/3556339 | PubMed |
| 2881455 | Pharmacology of the novel H2 antagonist famotidine: in vitro studies. | Agents Actions | 1986 | https://conductscience.org/library/papers/2881455 | PubMed |
| 2878860 | Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade. | Gut | 1986 | https://conductscience.org/library/papers/2878860 | PubMed |
| 2878342 | H2-receptor antagonists and gastric cancer. | Med Toxicol | 1986 | https://conductscience.org/library/papers/2878342 | PubMed |
| 2874823 | Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/2874823 | PubMed |
| 2867953 | Inhibition of acid and gastric carcinoids. | Gut | 1985 | https://conductscience.org/library/papers/2867953 | PubMed |
| 2667937 | Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. | Drugs | 1989 | https://conductscience.org/library/papers/2667937 | PubMed |
| 2573505 | Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases. | Drugs | 1989 | https://conductscience.org/library/papers/2573505 | PubMed |
| 2567661 | Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease. | Drugs | 1989 | https://conductscience.org/library/papers/2567661 | PubMed |
| 2437774 | Dimethyl sulfoxide inhibits histamine release induced by various chemicals. | Agents Actions | 1987 | https://conductscience.org/library/papers/2437774 | PubMed |
| 1704683 | Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium. | Agents Actions | 1990 | https://conductscience.org/library/papers/1704683 | PubMed |
| 1341077 | The biology and pathobiology of the ECL cells. | Yale J Biol Med | 1992 | https://conductscience.org/library/papers/1341077 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4041682
GET https://conductscience.org/api/papers/v1/4041682/authors